Episode 1: Demystifying Ketamine with Dr. Ken Adolph

Description
In this episode Dr. Jodi Midiri interviews Dr Ken Adolph a board-certified anesthesiologist, member of the American Society of Ketamine Physicians, and founder  of Illumma Ketamine Clinic.

Ketamine is a dissociative anesthesia that holds a lot of promise in treating mental health disorders when other treatments have failed.

Get the inside track in the latest thinking about ketamine treatment and administration 

References
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

Ketamine/esketamine: Putative mechanisms of action

The rebirth of psychedelic psychiatry

Ketamine for PTSD: Well, Isn’t That Special

Ketamine: Quo Vadis?

Is There Really Nothing New Under the Sun? 

Is Low-Dose Ketamine a Fast-Acting Antidepressant

Simply Because It Is An Opioid?

A Word to the Wise About Intranasal Esketamine

A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial

Further Investigation of Ketamine

Antisuicidal Effects of Ketamine: A Promising First Step

Effects of Ketamine Versus Midazolam on Neurocognition at 24 Hours in Depressed Patients With Suicidal Ideation.

Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression